文献速递神经肿瘤

成人髓母细胞瘤患者神经认知功能与健康相关生活质量:NOA-07研究长期结局

Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
PubMed 文献 · J Neurooncol · 2020-05-04

NOA-07研究对28/30例成人髓母细胞瘤患者进行长期随访,评估联合放化疗后的神经认知功能与健康相关生活质量(HRQoL)。结果显示HRQoL在治疗后30个月内临床相关改善(≥10分)但之后下降,言语工作记忆随访期间恶化且持续受损(z值低于-1个标准差),注意力治疗后受损并持续存在,而协调/处理速度和词汇言语流畅性改善并保持正常。

要点

  • HRQoL在治疗后30个月内改善≥10分,但之后下降。
  • 言语工作记忆随访期间恶化,z值持续低于-1个标准差。
  • 注意力治疗后受损并持续存在临床相关损害。

核心结论

  • NOA-07治疗方案与治疗后HRQoL恶化无关,但言语工作记忆恶化,其他神经认知域未受负面影响。

研究设计与样本

  • NOA-07研究的长期随访分析,纳入28/30例成人髓母细胞瘤患者,神经认知随访至18个月,HRQoL随访至60个月。

主要发现

  • 三个预设HRQoL量表(角色、社会、认知功能)较治疗后水平临床相关改善(≥10分)持续至30个月,之后下降。
  • 言语工作记忆z值随访期间较治疗后更差,18个月随访内持续受损(z值低于-1个标准差)。
  • 注意力治疗后受损,随访期间持续存在临床相关损害。
  • 协调/处理速度和词汇言语流畅性较治疗后改善,之后保持在正常范围。
  • 其他言语流畅性测试随时间稳定,z值在正常范围内。

关键数值与推荐

  • HRQoL临床相关改善定义为≥10分。
  • 言语工作记忆受损定义为z值低于-1个标准差。

临床怎么用

  • 成人髓母细胞瘤患者接受NOA-07方案后应长期监测言语工作记忆和注意力。
  • HRQoL在治疗后30个月后可能下降,需关注远期生活质量变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Combined radiochemotherapy followed by maintenance chemotherapy with cisplatin, lomustine and vincristine within the NOA-07 study resulted in considerable short-term toxicity in adult medulloblastoma patients. Here we investigated the long-term impact of this treatment, focusing on neurocognitive functioning and health-related quality of life (HRQoL). METHODS: Neurocognitive functioning and HRQoL scores over time were determined, and differences between the post-treatment and follow-up assessments were calculated up to 18 months for neurocognition and 60 months for HRQoL. RESULTS: 28/30 patients were analyzed. The three preselected HRQoL scales (role, social and cognitive functioning) showed improved scores, to a clinically relevant extent (≥ 10 points), compared to post-treatment levels up to 30 months, but decreased afterwards. Z-scores for verbal working memory were worse during follow-up compared to post-treatment scores and remained impaired during 18 months follow-up (i.e. z-score below - 1 standard deviation). Attention was impaired post-treatment, and remained impaired to a clinically relevant extent during follow-up. Coordination/processing speed and lexical verbal fluency improved compared to post-treatment scores, and remained within the normal range thereafter. Other tests of verbal fluency were stable over time, with z-scores within the normal range. CONCLUSIONS: This long-term follow-up study showed that the NOA-07 treatment regimen was not associated with a deterioration in HRQoL in the post-treatment period. Verbal working memory deteriorated, while other neurocognitive domains did not seem to be impacted negatively by the treatment.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Dirven L, Luerding R, Beier D, et al. Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study. J Neurooncol. 2020. PMID: 32367436. doi:10.1007/s11060-020-03502-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。